Results 31 to 40 of about 92,480 (295)

Crosstalk between Nrf2 and Notch signaling [PDF]

open access: yesFree Radical Biology and Medicine, 2015
The transcription factor Nrf2 (nuclear factor, erythroid derived 2, like 2) belongs to the CNC-bZip protein family, forming a transcriptosome with its direct heterodimer partner, sMaf, and co-factors such as CBP/p300. Nrf2 binds to one or more AREs (antioxidant response elements) that are located in the gene regulatory regions of the hundreds of Nrf2 ...
Nobunao Wakabayashi   +2 more
openaire   +2 more sources

NRF2 Enables EGFR Signaling in Melanoma Cells [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
Receptor tyrosine kinases (RTK) are rarely mutated in cutaneous melanoma, but the expression and activation of several RTK family members are associated with a proinvasive phenotype and therapy resistance. Epidermal growth factor receptor (EGFR) is a member of the RTK family and is only expressed in a subgroup of melanomas with poor prognosis.
Julia Katharina Charlotte Kreß   +4 more
openaire   +2 more sources

Monitoring the Antioxidant Mediated Chemosensitization and ARE-Signaling in Triple Negative Breast Cancer Therapy. [PDF]

open access: yesPLoS ONE, 2015
Chemotherapy often fails due to cellular detoxifying mechanisms, including phase-II enzymes. Activation of Nrf2-Keap1 pathway induces phase-II enzymes expression through ARE-signaling and prevents cancer development.
Kira Foygel   +2 more
doaj   +1 more source

Stimulation of Nuclear Factor (Erythroid-Derived 2)-like 2 Signaling by Nucleus Targeted Irradiation with Proton Microbeam

open access: yesBiology, 2023
Nuclear factor (erythroid-derived 2)-like 2 (NRF2), well-known as a master antioxidative response regulator in mammalian cells, is considered as a potential target for radiation protection and cancer therapy sensitization.
Jun Wang   +2 more
doaj   +1 more source

p62 links autophagy and Nrf2 signaling [PDF]

open access: yesFree Radical Biology and Medicine, 2015
The Nrf2-Keap1-ARE pathway is a redox and xenobiotic sensitive signaling axis that functions to protect cells against oxidative stress, environmental toxicants, and harmful chemicals through the induction of cytoprotective genes. To enforce strict regulation, cells invest a great deal of energy into the maintenance of the Nrf2 pathway to ensure rapid ...
Tao, Jiang   +5 more
openaire   +2 more sources

Recent Advances in the Role of Nuclear Factor Erythroid-2-Related Factor 2 in Spinal Cord Injury: Regulatory Mechanisms and Therapeutic Options

open access: yesFrontiers in Aging Neuroscience, 2022
Nuclear factor erythroid-2-related factor 2 (Nrf2) is a pleiotropic transcription factor, and it has been documented that it can induce defense mechanisms both oxidative stress and inflammatory injury.
Tianqi Jiang, Tianqi Jiang, Yongxiong He
doaj   +1 more source

Pentagalloylglucose reduces AGE-induced inflammation by activating Nrf2/HO-1 and inhibiting the JAK2/STAT3 pathway in mesangial cells

open access: yesJournal of Pharmacological Sciences, 2021
Pentagalloylglucose (PGG), a gallotannin polyphenolic compound, has been found to possess a host of beneficial pharmacologic activities, such as anti-inflammatory and antioxidative activities.
Jinzhi Tong   +9 more
doaj   +1 more source

Targeting NRF2 signaling for cancer chemoprevention [PDF]

open access: yesToxicology and Applied Pharmacology, 2010
Modulation of the metabolism and disposition of carcinogens through induction of cytoprotective enzymes is one of several promising strategies to prevent cancer. Chemopreventive efficacies of inducers such as dithiolethiones and sulforaphane have been extensively studied in animals as well as in humans.
Mi-Kyoung, Kwak, Thomas W, Kensler
openaire   +2 more sources

Targeting Nrf2/HO-1 anti-oxidant signaling pathway in the progression of multiple sclerosis and influences on neurological dysfunctions

open access: yesBrain Disorders, 2021
The nuclear factor erythroid 2-related factor (Nrf2) transcription factor/Hemoxygenase 1 (HO-1) is a primary regulator of essential cytoprotective responses in the brain.
Shubham Upadhayay   +1 more
doaj   +1 more source

The NRF2 antagonist ML385 inhibits PI3K‐mTOR signaling and growth of lung squamous cell carcinoma cells

open access: yesCancer Medicine, 2023
Background Lung squamous cell carcinoma (LUSC) currently has limited therapeutic options because of the relatively few validated targets and the lack of clinical drugs for some of these targets.
Lili Ji   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy